Cargando…
Development of a quaternary ammonium poly (amidoamine) dendrimer-based drug carrier for the solubility enhancement and sustained release of furosemide
Furosemide (FRSD) is a loop diuretic that has been categorized as a class IV drug according to the Biopharmaceutics Classification System (BCS). It is used in the treatment of congestive heart failure and edema. Owing to low solubility and permeability, its oral bioavailability is very poor. In this...
Autores principales: | Murugan, E., Yogaraj, V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982094/ https://www.ncbi.nlm.nih.gov/pubmed/36874076 http://dx.doi.org/10.3389/fchem.2023.1123775 |
Ejemplares similares
-
Erratum: Development of a quaternary ammonium poly (amidoamine) dendrimer-based drug carrier for the solubility enhancement and sustained release of furosemide
por: Frontiers Production Office
Publicado: (2023) -
Toxicology of Engineered Nanoparticles: Focus on Poly(amidoamine) Dendrimers
por: Naha, Pratap C., et al.
Publicado: (2018) -
Evaluation of poly(amidoamine) dendrimers as potential carriers of iminodiacetic derivatives using solubility studies and 2D-NOESY NMR spectroscopy
por: Markowicz, Magdalena, et al.
Publicado: (2012) -
In vitro antibacterial activity of poly (amidoamine)-G7 dendrimer
por: Gholami, Mitra, et al.
Publicado: (2017) -
Synthesis and characterization of fluorescence poly(amidoamine) dendrimer-based pigments
por: Golshan, Marzieh, et al.
Publicado: (2022)